{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:42:10Z","timestamp":1791186130864,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.lpm.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T03:17:17Z","timestamp":1377141437000},"page":"e303-e310","source":"Crossref","is-referenced-by-count":36,"special_numbering":"P2","title":["Drugs induced pulmonary arterial hypertension"],"prefix":"10.1016","volume":"42","author":[{"given":"Andrei","family":"Seferian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Camille","family":"Chaumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Tubert-Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2013.07.005_bib0010","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.lpm.2013.07.005_bib0015","first-page":"818","article-title":"Chronic pulmonary hypertension of vascular etiology, plexogenic pulmonary arteriopathy and the appetite depressant Aminorex: lessons from an epidemic","volume":"115","author":"Gurtner","year":"1985","journal-title":"Swiss Med Wkly"},{"issue":"2\u20133","key":"10.1016\/j.lpm.2013.07.005_bib0020","first-page":"160","article-title":"Aminorex and pulmonary hypertension. A review","volume":"27","author":"Gurtner","year":"1985","journal-title":"Cor et vasa"},{"issue":"20","key":"10.1016\/j.lpm.2013.07.005_bib0025","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/thx.26.3.262","article-title":"Aminorex and the pulmonary circulation","volume":"26","author":"Kay","year":"1971","journal-title":"Thorax"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.lpm.2013.07.005_bib0035","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1378\/chest.114.3_Supplement.195S","article-title":"Primary pulmonary hypertension associated with the use of fenfluramine derivatives","volume":"114","author":"Simonneau","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2013.07.005_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/rr181","article-title":"Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis","volume":"3","author":"Eddahibi","year":"2002","journal-title":"Respir Res"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.lpm.2013.07.005_bib0045","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1378\/chest.121.3_suppl.97S","article-title":"Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension","volume":"121","author":"Eddahibi","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.lpm.2013.07.005_bib0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mlc.2002.122181","article-title":"Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?","volume":"139","author":"Eddahibi","year":"2002","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herve","year":"1995","journal-title":"Am J Med"},{"issue":"2\u20133","key":"10.1016\/j.lpm.2013.07.005_bib0060","first-page":"111","article-title":"Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake","volume":"27","author":"Loogen","year":"1985","journal-title":"Cor et vasa"},{"issue":"6296","key":"10.1016\/j.lpm.2013.07.005_bib0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/bmj.283.6296.881","article-title":"Pulmonary hypertension fenfluramine","volume":"283","author":"Douglas","year":"1981","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/hrt.70.6.537","article-title":"Primary pulmonary hypertension fenfluramine use","volume":"70","author":"Brenot","year":"1993","journal-title":"Br Heart J"},{"issue":"9","key":"10.1016\/j.lpm.2013.07.005_bib0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00104807","article-title":"Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases","volume":"31","author":"Souza","year":"2008","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2013.07.005_bib0085","first-page":"445","article-title":"Effect of benfluorex on the metabolic fate of an oral glucose load in obese subjects with reduced glucose tolerance (author's transl)","volume":"34","author":"Krzentowski","year":"1979","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0090","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1183\/09031936.00086308","article-title":"Fenfluramine-like cardiovascular side-effects of benfluorex","volume":"33","author":"Boutet","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2013.07.005_bib0095","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.1371\/journal.pone.0010128","article-title":"Benfluorex and unexplained valvular heart disease: a case-control study","volume":"5","author":"Frachon","year":"2010","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.lpm.2013.07.005_bib0100","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1183\/09031936.00188611","article-title":"Pulmonary hypertension associated with benfluorex exposure","volume":"40","author":"Savale","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.104.2.614","article-title":"Pulmonary hypertension associated with long-term inhalation of \u201ccrank\u201d methamphetamine","volume":"104","author":"Schaiberger","year":"1993","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0002-8703(95)90459-X","article-title":"Pulmonary artery hypertension in chronic intravenous cocaine users","volume":"130","author":"Yakel","year":"1995","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0954-6111(96)90160-2","article-title":"Acute, reversible pulmonary hypertension associated with cocaine use","volume":"90","author":"Collazos","year":"1996","journal-title":"Respir Med"},{"issue":"23","key":"10.1016\/j.lpm.2013.07.005_bib0120","first-page":"1283","article-title":"Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping","volume":"149","author":"van Wolferen","year":"2005","journal-title":"Nederlands tijdschrift voor geneeskunde"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0125","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.130.6.1657","article-title":"Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?","volume":"130","author":"Chin","year":"2006","journal-title":"Chest"},{"issue":"10\u201312","key":"10.1016\/j.lpm.2013.07.005_bib0130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s007020050121","article-title":"Expression of a pulmonary endothelial norepinephrine transporter","volume":"105","author":"Tseng","year":"1998","journal-title":"J Neural Transm"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0135","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1378\/chest.115.6.1708","article-title":"Alpha1-adrenergic hypothesis for pulmonary hypertension","volume":"115","author":"Salvi","year":"1999","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.lpm.2013.07.005_bib0140","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.RES.0000126847.27660.69","article-title":"Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension","volume":"94","author":"Marcos","year":"2004","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.lpm.2013.07.005_bib0145","first-page":"723","article-title":"Synergistic interactions between fenfluramine and phentermine","volume":"23","author":"Wellman","year":"1999","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0150","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.117.3.870","article-title":"Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension","volume":"117","author":"Rich","year":"2000","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1253\/jcj.64.218","article-title":"Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report","volume":"64","author":"Hagiwara","year":"2000","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.lpm.2013.07.005_bib0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.sleep.2012.07.008","article-title":"Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review","volume":"14","author":"Nittur","year":"2013","journal-title":"Sleep Med"},{"issue":"14","key":"10.1016\/j.lpm.2013.07.005_bib0165","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.lpm.2013.07.005_bib0170","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0175","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2006-09-047266","article-title":"Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy","volume":"109","author":"Hochhaus","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood-2006-07-035493","article-title":"Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure","volume":"109","author":"Quintas-Cardama","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.lpm.2013.07.005_bib0185","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/bmt.2008.415","article-title":"Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient","volume":"43","author":"Mattei","year":"2009","journal-title":"Bone Marrow Transplan"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0190","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.leukres.2008.09.026","article-title":"Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia","volume":"33","author":"Rasheed","year":"2009","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.lpm.2013.07.005_bib0195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1183\/09031936.00154210","article-title":"Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia","volume":"38","author":"Dumitrescu","year":"2011","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1016\/j.lpm.2013.07.005_bib0200","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","article-title":"Pulmonary arterial hypertension in patients treated by dasatinib","volume":"125","author":"Montani","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lpm.2013.07.005_bib0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/09031936.00091912","article-title":"Key roles of Src family tyrosine kinases in the integrity of the pulmonary vascular bed","volume":"41","author":"Guignabert","year":"2013","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0210","first-page":"1863","article-title":"Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal","volume":"22","author":"Dusheiko","year":"1995","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1016\/j.lpm.2013.07.005_bib0215","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0002-9378(95)90402-6","article-title":"Interferons: biochemistry and mechanisms of action","volume":"172","author":"Tyring","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2013.07.005_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0079-6603(08)60026-4","article-title":"The interferon genes","volume":"33","author":"Weissmann","year":"1986","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"issue":"22","key":"10.1016\/j.lpm.2013.07.005_bib0225","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.Hepatitis Interventional Therapy Group","volume":"321","author":"Davis","year":"1989","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0016-5085(94)90131-7","article-title":"A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C","volume":"107","author":"Brillanti","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lpm.2013.07.005_bib0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ajh.10319","article-title":"Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies","volume":"73","author":"Anderson","year":"2003","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0240","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-010-1220-7","article-title":"Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C","volume":"55","author":"Dhillon","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(99)00107-7","article-title":"Interferon-alpha elevates pulmonary blood pressure in sheep-the role of thromboxane cascade","volume":"370","author":"Hanaoka","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.lpm.2013.07.005_bib0250","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1517\/14712598.7.4.535","article-title":"Interferon-beta1a for the treatment of multiple sclerosis","volume":"7","author":"Clerico","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.lpm.2013.07.005_bib0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000335064","article-title":"Sildenafil therapy for interferon-beta-1a-induced pulmonary arterial hypertension: a case report","volume":"120","author":"Caravita","year":"2011","journal-title":"Cardiology"},{"issue":"7","key":"10.1016\/j.lpm.2013.07.005_bib0260","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1352458509104593","article-title":"Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report","volume":"15","author":"Ledinek","year":"2009","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.lpm.2013.07.005_bib0265","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1378\/chest.97.5.1032","article-title":"Pulmonary disease associated with l-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features","volume":"97","author":"Tazelaar","year":"1990","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lpm.2013.07.005_bib0270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0002-9343(91)80175-L","article-title":"Pulmonary hypertension in a patient with tryptophan-induced eosinophilia-myalgia syndrome","volume":"90","author":"Yakovlevitch","year":"1991","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0275","first-page":"867","article-title":"The eosinophilia-myalgia syndrome: the Los Alamos Conference","volume":"18","author":"Hertzman","year":"1991","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.lpm.2013.07.005_bib0280","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00011-005-1380-7","article-title":"A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation","volume":"54","author":"Smith","year":"2005","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ahj.2006.02.020","article-title":"Temporal trends and drug exposures in pulmonary hypertension: an American experience","volume":"152","author":"Walker","year":"2006","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.lpm.2013.07.005_bib0290","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1136\/hrt.2004.036491","article-title":"Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure","volume":"90","author":"Barst","year":"2004","journal-title":"Heart"},{"issue":"9416","key":"10.1016\/j.lpm.2013.07.005_bib0295","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0300","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neurol.2007.09.005","article-title":"Isolated pulmonary hypertension and pergolide","volume":"164","author":"Evrard","year":"2008","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.lpm.2013.07.005_bib0305","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-8703(86)90065-7","article-title":"Persistent pulmonary hypertension of the newborn","volume":"111","author":"Tiefenbrunn","year":"1986","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.lpm.2013.07.005_bib0310","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.07.005_bib0315","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"BMJ"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213006672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213006672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T20:27:15Z","timestamp":1539462435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213006672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0755498213006672"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.07.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}